By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...

Two new sub-types of multiple sclerosis (MS) were discovered by researchers from Queen Square Analytics and University ...

Using artificial intelligence (AI), researchers looked at brain scans and tested for a blood marker for nerve cell injury and ...

Paramagnetic rim lesions and other imaging biomarkers that show up on MRI allow patients to be diagnosed and treated much sooner.

Myelin loss disrupts the coordination of signals between brain regions, impairing the accurate processing of information, researchers found.

Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...

New research reveals that even a small loss of myelin—the protective coating around neurons—can severely disrupt how the brain sends and interprets sensory information.

Teriflunomide (Aubagio, Genzyme/Sanofi), a once-daily oral medication approved for relapsing-remitting multiple sclerosis (RRMS), significantly slows brain volume loss in these patients, a reanalysis ...